Ocular Therapeutix Inc (NASDAQ:OCUL)’s traded shares stood at 1.55 million during the latest session, with the company’s beta value hitting 1.37. At the last check today, the stock’s price was $6.84, to imply a decrease of -9.76% or -$0.74 in intraday trading. The OCUL share’s 52-week high remains $11.31, putting it -65.35% down since that peak but still an impressive 70.76% since price per share fell to its 52-week low of $2.00. The company has a valuation of $1.02B, with an average of 2.07 million shares over the past 3 months.

Ocular Therapeutix Inc (NASDAQ:OCUL) trade information

After registering a -9.76% downside in the latest session, Ocular Therapeutix Inc (OCUL) has traded red over the past five days. The stock hit a weekly high of 8.35, dropping -9.76% in its intraday price action. The 5-day price performance for the stock is -17.39%, and -29.48% over 30 days. With these gigs, the year-to-date price performance is 53.36%.

Ocular Therapeutix Inc (OCUL) estimates and forecasts

Looking at statistics comparing Ocular Therapeutix Inc share performance against respective industry, we note that the company has outperformed competitors. Ocular Therapeutix Inc (OCUL) shares are 161.07% up over the last 6 months, with its year-to-date growth rate higher than industry average at 33.33% against 9.60%. Revenue is forecast to grow 51.30% this quarter before jumping 23.10% for the next one. The rating firms project that company’s revenue will grow 16.90% compared to the previous financial year.

Revenue forecast for the current quarter as set by 7 analysts is $15.41 million. Meanwhile, for the quarter ending Jun 2024, a total of 7 analyst(s) estimate revenue growth to $16.38 million.Earnings reports from the last fiscal year show that sales brought in $13.37 million and -$ respectively in the corresponding quarters.

OCUL Dividends

Ocular Therapeutix Inc has its next earnings report out in May. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Ocular Therapeutix Inc has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.